DEXCOM INC (DXCM) closed fiscal year 2025 with a gross margin of 60.1 % and a net margin of 17.9 %.
DEXCOM INC (DXCM) closed fiscal year 2025 with a gross margin of 60.1 % and a net margin of 17.9 %. The same year shows an EBITDA margin of 25.0 % and an EBIT margin of 19.6 %. The free cash flow margin was 23.1 %. Against the previous year the gross margin moved −0.4 pp and the net margin +3.7 pp. Across the period the gross margin ranges between 12.3 % in 2009 and 69.3 % in 2015. The series covers 17 fiscal years, from 2009 to 2025. Margins are expressed as a percentage of net revenue and are derived from the same figures as the income statement, taken from as-reported SEC EDGAR filings, with no restatements or adjustments of our own.
Fiscal year end: December
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin (%) | 12.33 % | 37.86 % | 47.05 % | 46.65 % | 62.56 % | 68.02 % | 69.25 % | 66.00 % | 68.49 % | 64.36 % | 63.11 % | 66.44 % | 68.63 % | 64.72 % | 63.19 % | 60.46 % | 60.10 % |
| EBITDA margin (%) | -146.36 % | -88.27 % | -53.74 % | -49.15 % | -13.69 % | -5.05 % | -11.52 % | -8.53 % | -3.67 % | -15.24 % | 12.94 % | 19.03 % | 15.02 % | 18.80 % | 21.64 % | 20.28 % | 24.96 % |
| EBIT margin (%) | -154.36 % | -93.21 % | -58.72 % | -55.76 % | -18.06 % | -8.29 % | -14.20 % | -11.15 % | -5.92 % | -18.06 % | 9.64 % | 15.54 % | 10.86 % | 13.44 % | 16.50 % | 14.88 % | 19.56 % |
| Net margin (%) | -180.26 % | -113.58 % | -58.58 % | -54.55 % | -18.63 % | -8.64 % | -14.33 % | -11.44 % | -6.99 % | -12.32 % | 6.85 % | 28.53 % | 8.86 % | 11.73 % | 14.95 % | 14.29 % | 17.94 % |
| FCF margin (%) | -142.73 % | -102.06 % | -49.93 % | -42.64 % | -3.44 % | 2.85 % | 3.91 % | 0.09 % | 3.62 % | 5.44 % | 9.11 % | 14.36 % | 2.18 % | 10.47 % | 14.13 % | 15.64 % | 23.11 % |
